Uncovering Institutional Buying In Ironwood Pharmaceuticals Inc (NASDAQ: IRWD)
Currently, there are 160.02M common shares owned by the public and among those 155.19M shares have been available to trade. The company’s stock has a 5-day price change of -13.76% and -59.66% over the past three months. IRWD shares are trading -57.56% year to date (YTD), with the 12-month market performance down to -87.38% lower. […]
Following The Money: Institution’s Growing Stake In Ironwood Pharmaceuticals Inc (NASDAQ: IRWD)
Ironwood Pharmaceuticals Inc (IRWD) concluded trading on Thursday at a closing price of $1.94, with 9.31 million shares of worth about $18.05 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -68.04% during that period and on February 06, 2025 the price saw a […]
Is Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Proving The Doubters Wrong?
Ironwood Pharmaceuticals Inc (IRWD) concluded trading on Thursday at a closing price of $2.30, with 10.5 million shares of worth about $24.14 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -66.86% during that period and on January 30, 2025 the price saw a […]
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD): Analyst View Points To Future Growth
Ironwood Pharmaceuticals Inc (IRWD) concluded trading on Wednesday at a closing price of $15.45, with 5.01 million shares of worth about $77.45 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 56.69% during that period and on Wednesday the price saw a gain of […]
An Important Check-Up On Ironwood Pharmaceuticals Inc (NASDAQ: IRWD)
Ironwood Pharmaceuticals Inc (IRWD) concluded trading on Thursday at a closing price of $14.60, with 3.55 million shares of worth about $51.83 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 31.06% during that period and on Thursday, February 01 price saw a gain […]
Ironwood Pharmaceuticals Inc (IRWD) Volatility Spurs A Quest For Clarity
The Vanguard Group, Inc. recently announced the acquisition of new stake in Ironwood Pharmaceuticals Inc (NASDAQ:IRWD). The institutional investor has increased its shareholding in the Healthcare company by 10.10% to 16.03 million shares with purchase of 1.47 million shares. This fresh investment now brings its stake to 10.27% valued currently at $183.42 million. In addition, […]
There Is Clear Momentum For Ironwood Pharmaceuticals Inc (NASDAQ: IRWD)
Ironwood Pharmaceuticals Inc (IRWD) concluded trading on 01/11/24 at a closing price of $12.24, with 2.41 million shares of worth about $29.55 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 18.49% during that period and on Thursday the price saw a loss of […]
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Not A Good Play Anymore?
The Vanguard Group, Inc. has recently announced that it has increased stake in Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) by 0.36%. After grabbing 14.56 million shares, the institutional investor is now in possession of 52828.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.33% having worth around $144.18 million. Moreover, […]
